PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Fifteen-year results from SWOG S0016 trial suggest follicular lymphoma is curable

Long-term data on patients treated with a standard chemoimmunotherapy combination show relapse rates dropped over time and 70 percent of patients were still alive 15 years later, with an overall cure rate estimated at 42 percent of patients treated

2026-02-26
(Press-News.org)

Unlike some other forms of lymphoma, advanced stage follicular lymphoma is considered incurable. But a new analysis of long-term data on patients treated for the disease years ago with standard regimens of immunotherapy and a chemotherapy combination known as CHOP suggests that many of those patients can now be considered cured.

The analysis is just published in the journal JAMA Oncology. 

“A subset of advanced-stage follicular lymphoma patients can achieve cure with CHOP-based chemoimmunotherapy, as relapse rates decline over time,” said Wilmot Cancer Institute Director Jonathan W. Friedberg, MD, MMSc, at the University of Rochester Medical Center, who is senior and corresponding author on the paper. 

“This finding represents a paradigm shift in our understanding and approach to follicular lymphoma, with broad implications for initial patient discussions and future research strategies.”

Historically, follicular lymphoma has been considered an incurable disease, with most patients experiencing relapses even years after initial treatment.

The JAMA Oncology paper reports on an analysis of follow-up data from patients with advanced follicular lymphoma who had been treated with a standard first-line chemoimmunotherapy regimen on a large clinical trial.

Roughly 70 percent of the patients remained alive 15 years after beginning treatment, and a statistical method known as cure modeling estimated that 42 percent of treated patients had been cured.

Cure modeling incorporates background mortality rates in an analysis of patient survival data to estimate what fraction of a group of patients can be considered cured of a disease. Such modeling accounts for the fact that over time some patient deaths will occur that are unrelated to the given disease.

The researchers applied a cure model to 15-year follow-up data from the S0016 clinical trial (NCT00006721) conducted by the SWOG Cancer Research Network, a clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), with the participation of other groups within the NCI-funded National Clinical Trials Network (NCTN).

This phase 3 trial, which opened in 2001, enrolled patients with untreated advanced-stage CD20-positive follicular lymphoma and randomized 531 of them to one of two treatments, both of which were built around a core chemotherapy regimen known as CHOP (cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone). One arm treated patients with rituximab plus the CHOP combination (R-CHOP), while the other arm used CHOP followed by radioimmunotherapy (CHOP-RIT). Primary results of the S0016 trial were published in 2013 (Press, OW. J Clin Oncol. 2013).

The S0016 modeling, including cure analysis, was carried out by Michael LeBlanc, PhD, a biostatistician at Fred Hutch Cancer Center and director of SWOG’s Statistics and Data Management Center (SDMC), and Hongli Li, MS, also at the Hutch and the SWOG SDMC. 

It showed that, with a median follow-up time of 15.5 years after a patient had begun treatment, the rate of disease relapse dropped substantially over time, falling from 6.8 percent of patients relapsing in the first 5 years to only 0.6 percent relapsing between years 15 and 20.

Fifteen years after starting treatment, about 70 percent of patients remained alive. The analysis also showed no statistically significant difference between the two treatment arms in the rates of 15-year overall survival.

Based on their work, the authors conclude that a substantial subset of patients with advanced-stage follicular lymphoma can, when treated with a standard regimen that includes immunotherapy and chemotherapy, achieve a functional cure – defined as having no chance of lymphoma recurring during the patient’s expected lifespan.

“These results reinforce that front-line chemoimmunotherapy remains an important option—particularly for appropriate patients—because it can deliver long-term disease control after a time-limited course of treatment, ” said Mazyar Shadman, MD, MPH, of Fred Hutch Cancer Center, who is first author on the paper. Shadman is medical director of cellular immunotherapy at Fred Hutch, where he holds the Innovators Network Endowed Chair.

“As we bring novel agents into the first-line setting, the durability seen here sets a high benchmark; new strategies should aim not only to improve short-term response rates but to match or exceed long-term remission and cure potential.”

The idea that many of these patients can be cured could change how newly diagnosed patients are counseled and could eliminate the need for indefinite oncology and radiologic follow-up visits after treatment, with patients eventually transitioning from oncology care back to a primary care team.

This study was supported by the NIH/NCI through grants U10CA180888 and U10CA180819.

Additional authors on the paper include Lisa Rimsza, MD, University of Arizona; John P. Leonard, MD, New York University; and Sonali M. Smith, MD, University of Chicago Medicine.
 

SWOG Cancer Research Network is part of the National Cancer Institute's National Clinical Trials Network and the NCI Community Oncology Research Program and is part of the oldest and largest publicly funded cancer research network in the nation. SWOG has more than 20,000 members in 46 states and seven other countries who design and conduct clinical trials to improve the lives of people with cancer. SWOG trials have directly led to FDA approval of 14 cancer drugs, changed more than 100 standards of cancer care, and saved more than 3 million years of human life. Learn more at swog.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

The breasts of a breastfeeding mother may protect a newborn from the cold – researchers offer a new perspective on breast evolution

2026-02-26
Breasts are necessary for breastfeeding, but their size is not decisive in terms of milk production. A large part of the breast consists of adipose tissue, and earlier theories have suggested that they function, for example, as a body fat reserve. Another theory proposes that breasts evolved through sexual selection as a signal of individual fitness, similar to facial symmetry. The University of Oulu study examined the possible role of breasts in the thermoregulation of a breastfeeding infant. Newborns are particularly susceptible to hypothermia because their own thermoregulatory system is still underdeveloped. The ...

More organ donations now come from people who die after their heart stops beating

2026-02-26
Organ donation after the heart stops beating, a practice called donation after circulatory death, has gone from rare to routine in the United States, a new study shows. This shift over the past 25 years, aided by technological advances, is helping to meet the growing demand for transplants, the authors say.  More than 100,000 Americans are currently waiting for a lifesaving transplant, according to the United Network for Organ Sharing. To address the shortage, experts have long searched for ways to safely and ethically increase the number of usable organs recovered from people who die.  Led by NYU Langone Health researchers, the new analysis traced how the deceased-donor ...

How stepping into nature affects the brain

2026-02-26
Spending time in nature, even briefly, triggers changes in the brain that calm stress, restore attention and quiet mental clutter, a new study has found. Researchers at McGill University and colleagues at Adolfo Ibáñez University in Chile have examined more than 100 brain-imaging studies from various disciplines. The result is one of the most comprehensive reviews to date of how the brain responds to nature. The findings add neuroscientific weight to the emerging field of nature connectedness, which seeks to better ...

Study: Cancer’s clues in the bloodstream reveal the role androgen receptor alterations play in metastatic prostate cancer

2026-02-26
MIAMI, FLORIDA (EMBARGOED UNTIL FEB. 26, 2026, AT 10 A.M. EST) – A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that androgen receptor (AR) alterations consistently emerged and were linked to poorer outcomes across therapies. The findings, published Feb. 26 in Clinical Cancer Research, a journal of the American Association for Cancer Research, suggest that a single genomic test at diagnosis is no longer sufficient for managing advanced prostate cancer ...

FAU Harbor Branch awarded $900,000 for Gulf of America sea-level research

2026-02-26
The Gulf of America is experiencing accelerated sea-level rise due to a complex interplay of ocean dynamics, steric effects and vertical land motion. These changes pose serious challenges for coastal communities, particularly rural and under-resourced areas that lack the infrastructure and data to plan for flooding and long-term adaptation. Understanding the drivers of regional sea-level variability and developing actionable forecasting tools is critical for supporting decision-making and resilience planning. Florida Atlantic University’s Harbor Branch Oceanographic Institute has been awarded a $900,000, four-year ...

Terminal ileum intubation and biopsy in routine colonoscopy practice

2026-02-26
Background and objectives Terminal ileum intubation is considered the completion step of colonoscopy and is usually performed to assess the ileum. The histological examination of the ileal mucosa, which is acquired during terminal ileum intubation, may allow an accurate diagnosis. However, there is no absolute consensus on when ileoscopy and biopsy should be attempted. As a result, we aimed to evaluate whether terminal ileum intubation and biopsy should be performed routinely. Methods Systematic searches were performed in the PubMed, EMBASE, and Cochrane Library databases, as well as the Science Citation Index via the Web of Science ...

Researchers find important clue to healthy heartbeats

2026-02-26
PULLMAN, Wash. — A tiny region in a little-known muscle protein may hold the key to a healthy, steady heartbeat, as well as possible clues to future treatment of devastating heart ailments. Washington State University researchers have found a region of a protein called leiomodin that is critical in maintaining the length of tiny filaments that control a person’s heartbeat. The work, in collaboration with researchers from the University of Arizona and Mount Sinai School of Medicine in New York, is featured in the high-profile journal Circulation Research. “It’s a small part of a big protein ...

Characteristic genomic and clinicopathologic landscape of DNA polymerase epsilon mutant colorectal adenocarcinomas

2026-02-26
Background and objectives DNA polymerase epsilon catalytic subunit A (POLE) gene plays a crucial role in DNA repair and chromosomal replication. Mutations in the POLE gene have been linked to cancer, particularly colorectal carcinoma (CRC). However, the genomic landscape and pathological significance of POLE mutant CRC remain underreported. This study aimed to characterize the clinicopathologic features and genomic landscape of CRC harboring POLE mutations and to investigate the implications of co-occurring genetic alterations. Methods We ...

Start school later, sleep longer, learn better

2026-02-26
High school students often have trouble getting to bed at a reasonable time, which makes it difficult for them to start school early in the morning. This is because teenagers are biologically wired to fall asleep later than adults, with their biological clock shifting progressively later throughout adolescence. The result is that most teenagers don’t get enough sleep on school days, and their sleep deficits increase as the week progresses. “This is concerning, as chronic sleep deprivation not only affects well-being, but also has a measurable impact on mental health, physical ...

Many nations underestimate greenhouse emissions from wastewater systems, but the lapse is fixable

2026-02-26
Nations worldwide underestimate greenhouse gas emissions from wastewater facilities, but updating measurements could fix this. Nations worldwide underestimate greenhouse gas emissions from wastewater systems, research from Princeton University shows. Outdated inventory methods and failure to include items like latrines and untreated sewage in national reports are main reasons. In an article published Feb. 11 in the journal Nature Climate Change, the researchers report that nations underestimated emissions of gases including methane ...

LAST 30 PRESS RELEASES:

New PET imaging study reveals how ketamine relieves treatment-resistant depression

New study reveals differences between anime bamboo muzzle and actual bamboo

The ‘Great Texas Freeze’ killed thousands of purple martins; biologists worry recovery could take decades

Cancer has a unique nuclear metabolic fingerprint

Tiny thermometers offer on-chip temperature monitoring for processors

New compound stops common complications after intestinal surgery

Breaking through water treatment limits with defect-free, high-efficiency next-generation ceramic filters!

Researchers determine structural motifs of water undecamer cluster

Researchers enhance photocatalytic hydrogen evolution performance of covalent organic frameworks by constitutional isomer strategy

Molecular target drives immunogenicity in cancer immunotherapy

Plant cell structure could hold key to cancer therapies and improved crops

Sustainable hydrogen peroxide production: Breakthroughs in electrocatalyst design for on-site synthesis

Cash rewards for behavior change: A review of financial incentives science in one health contexts and implications

One Health antimicrobial resistance modelling: from science to policy

Artificial feeding platform transforms study of ticks and their diseases

Researchers uncover microscopic mechanism of alkali species dissolution in water clusters

Methionine restriction for cancer therapy: A comprehensive review of mechanisms and clinical applications

White House autism briefing linked to swift shifts in prescribing patterns, study finds

Specialist palliative care can save the NHS up to £8,000 per person and improves quality of life

New research warns charities against ‘AI shortcut’ to empathy

Cannabis compounds show promise in fighting fatty liver disease

Study in mice reveals the brain circuits behind why we help others

Online forum to explore how organic carbon amendments can improve soil health while storing carbon

Turning agricultural plastic waste into valuable chemicals with biochar catalysts

Hidden viral networks in soil microplastics may shape the future of sustainable agriculture

Americans don’t just fear driverless cars will crash — they fear mass job losses

Mayo Clinic researchers find combination therapy reduces effects of ‘zombie cells’ in diabetic kidney disease

Preventing breast cancer resistance to CDK4/6 inhibitors using genomic findings

Carbon nanotube fiber ‘textile’ heaters could help industry electrify high-temperature gas heating

Improving your biological age gap is associated with better brain health

[Press-News.org] Fifteen-year results from SWOG S0016 trial suggest follicular lymphoma is curable
Long-term data on patients treated with a standard chemoimmunotherapy combination show relapse rates dropped over time and 70 percent of patients were still alive 15 years later, with an overall cure rate estimated at 42 percent of patients treated